Clarivate's Bold Moves: Shaping the Future of Research and Medtech
September 26, 2024, 11:50 pm
In a world where knowledge is power, Clarivate Plc is stepping up to the plate. The company is not just a player; it’s a game-changer. With two recent announcements, Clarivate is redefining how we evaluate research impact and streamline medtech sales. These initiatives are like two sides of a coin, each reflecting a commitment to innovation and societal benefit.
First, let’s dive into the societal impact of research. Clarivate has unveiled a comprehensive framework aimed at evaluating the societal impact of research. This is a response to a growing demand. Funders, governments, and institutions are under pressure to show that their investments yield tangible benefits. The new framework, detailed in a report by the Institute for Scientific Information (ISI), goes beyond traditional metrics. It’s not just about the number of papers published or citations received. It’s about real-world effects.
Imagine a vast tapestry. Each thread represents a different facet of society: political, economic, medical, and more. Clarivate’s framework weaves these threads together, creating a holistic view of research impact. It categorizes societal needs into eight distinct areas. This approach recognizes that society is complex and multifaceted. Each area is not just a box to check; it’s a lens through which to assess the true value of research.
The framework balances qualitative and quantitative methods. It’s like a painter using both broad strokes and fine details. Traditional metrics often miss the nuances. Clarivate’s approach allows for richer assessments. It captures the essence of research beyond mere numbers. This is crucial in an era where the impact of research can take years, even decades, to materialize.
To tackle the challenge of time, the framework introduces both lagging and leading indicators. Lagging indicators look back, analyzing past outputs. Leading indicators, on the other hand, are forward-looking. They identify recent signals that suggest future benefits. This dual approach is like having a rearview mirror and a GPS. It helps researchers navigate the long road from discovery to societal application.
The report emphasizes transparency. Each facet of the framework includes multiple metrics. This allows for detailed evaluations tailored to specific needs. Users can create a Societal Impact Profile™, showcasing their research’s contributions. It’s a powerful tool for researchers and institutions alike.
Now, let’s shift gears to the medtech sector. Clarivate has forged a strategic partnership with Relatable Healthcare. This collaboration aims to transform the sales contracting process in the medical technology industry. In a landscape where efficiency is key, this partnership is a breath of fresh air.
Relatable Healthcare offers a Product Relationship Management (PRM) platform. This platform serves as a single source of truth for medtech manufacturers and distributors. It centralizes product data, competitive intelligence, and sales collateral. This is crucial in a field where information is often scattered and hard to access. With this partnership, Clarivate enhances its market intelligence offerings. It’s like giving medtech companies a high-powered telescope to spot opportunities in a crowded market.
The medtech industry faces unique challenges. Companies must communicate product value effectively while navigating cost constraints. Healthcare providers are meticulous in their purchasing decisions. They compare devices and supplies with a fine-tooth comb. This is where the partnership shines. By combining Clarivate’s deep market knowledge with Relatable’s software, medtech companies can streamline their sales processes. They can make informed pricing decisions and enhance contract compliance.
The collaboration empowers medtech teams. It allows them to automate workflows across contracting, sales, and marketing. This efficiency translates to faster product commercialization. It’s about getting products to patients quicker. In a world where time is often of the essence, this is a significant advantage.
Both initiatives reflect Clarivate’s commitment to innovation. The societal impact framework and the medtech partnership are not isolated efforts. They are part of a broader strategy to enhance research and healthcare outcomes. Clarivate is positioning itself as a leader in transformative intelligence. It’s about more than just data; it’s about driving change.
In conclusion, Clarivate is at the forefront of two critical areas: research evaluation and medtech sales. The new framework for assessing societal impact is a significant step forward. It addresses the complexities of measuring research benefits in a nuanced way. Meanwhile, the partnership with Relatable Healthcare is set to revolutionize the medtech industry. Together, these initiatives are not just about numbers; they are about making a difference. Clarivate is not just shaping the future; it’s redefining it. The road ahead is bright, and the potential for societal benefit is immense.
First, let’s dive into the societal impact of research. Clarivate has unveiled a comprehensive framework aimed at evaluating the societal impact of research. This is a response to a growing demand. Funders, governments, and institutions are under pressure to show that their investments yield tangible benefits. The new framework, detailed in a report by the Institute for Scientific Information (ISI), goes beyond traditional metrics. It’s not just about the number of papers published or citations received. It’s about real-world effects.
Imagine a vast tapestry. Each thread represents a different facet of society: political, economic, medical, and more. Clarivate’s framework weaves these threads together, creating a holistic view of research impact. It categorizes societal needs into eight distinct areas. This approach recognizes that society is complex and multifaceted. Each area is not just a box to check; it’s a lens through which to assess the true value of research.
The framework balances qualitative and quantitative methods. It’s like a painter using both broad strokes and fine details. Traditional metrics often miss the nuances. Clarivate’s approach allows for richer assessments. It captures the essence of research beyond mere numbers. This is crucial in an era where the impact of research can take years, even decades, to materialize.
To tackle the challenge of time, the framework introduces both lagging and leading indicators. Lagging indicators look back, analyzing past outputs. Leading indicators, on the other hand, are forward-looking. They identify recent signals that suggest future benefits. This dual approach is like having a rearview mirror and a GPS. It helps researchers navigate the long road from discovery to societal application.
The report emphasizes transparency. Each facet of the framework includes multiple metrics. This allows for detailed evaluations tailored to specific needs. Users can create a Societal Impact Profile™, showcasing their research’s contributions. It’s a powerful tool for researchers and institutions alike.
Now, let’s shift gears to the medtech sector. Clarivate has forged a strategic partnership with Relatable Healthcare. This collaboration aims to transform the sales contracting process in the medical technology industry. In a landscape where efficiency is key, this partnership is a breath of fresh air.
Relatable Healthcare offers a Product Relationship Management (PRM) platform. This platform serves as a single source of truth for medtech manufacturers and distributors. It centralizes product data, competitive intelligence, and sales collateral. This is crucial in a field where information is often scattered and hard to access. With this partnership, Clarivate enhances its market intelligence offerings. It’s like giving medtech companies a high-powered telescope to spot opportunities in a crowded market.
The medtech industry faces unique challenges. Companies must communicate product value effectively while navigating cost constraints. Healthcare providers are meticulous in their purchasing decisions. They compare devices and supplies with a fine-tooth comb. This is where the partnership shines. By combining Clarivate’s deep market knowledge with Relatable’s software, medtech companies can streamline their sales processes. They can make informed pricing decisions and enhance contract compliance.
The collaboration empowers medtech teams. It allows them to automate workflows across contracting, sales, and marketing. This efficiency translates to faster product commercialization. It’s about getting products to patients quicker. In a world where time is often of the essence, this is a significant advantage.
Both initiatives reflect Clarivate’s commitment to innovation. The societal impact framework and the medtech partnership are not isolated efforts. They are part of a broader strategy to enhance research and healthcare outcomes. Clarivate is positioning itself as a leader in transformative intelligence. It’s about more than just data; it’s about driving change.
In conclusion, Clarivate is at the forefront of two critical areas: research evaluation and medtech sales. The new framework for assessing societal impact is a significant step forward. It addresses the complexities of measuring research benefits in a nuanced way. Meanwhile, the partnership with Relatable Healthcare is set to revolutionize the medtech industry. Together, these initiatives are not just about numbers; they are about making a difference. Clarivate is not just shaping the future; it’s redefining it. The road ahead is bright, and the potential for societal benefit is immense.